Lumine Group Enters into an Agreement to Acquire Datafusion Systems
TORONTO, May 23, 2025 (GLOBE NEWSWIRE) —
Lumine Group Inc.
('Lumine Group' or 'the Company') (TSXV: LMN), a global buy-and-hold forever acquirer of communications and media software businesses, today announced that it has entered into an agreement to acquire Datafusion Systems ('Datafusion').
Headquartered in Dubai, UAE, and backed by over 30 years of expertise, Datafusion provides critical secure communication and intelligence solutions for telecom operators, law enforcement, and government agencies.
This acquisition will enhance Lumine's presence in the signaling and security sector, broadening the ecosystem's product offerings and market reach. In addition, with Datafusion headquartered in Dubai, once the transaction closes, this will mark Lumine Group's first acquisition in the UAE.
'Datafusion will be a strong and exciting addition to Lumine Group,' said Tony Garcia, Chief Operating Officer at Lumine Group. 'With an increasing focus on public safety and early threat detection, telecom operators, law enforcement, and government agencies have an ongoing pressing need for real time secure communication and intelligence solutions. Datafusion brings deep expertise and a solid track record in this sector, and we are excited to welcome them to Lumine Group, to share our best practices, and to learn from their decades of industry insight.'
'Joining Lumine Group will mark an exciting new chapter for our team,' said John Senior, CEO of Datafusion. 'Lumine Group's long-term, buy-and-hold philosophy aligns closely with our own values and particularly that of our long-term customers and partners. With over three decades of experience, we are looking forward to completing this transaction and reinforcing our commitment to our customers and current regions, while exploring new opportunities for global growth. We look forward to what we can accomplish with Lumine Group in this next chapter.'
Closing is expected by early Q3, following customary Dubai Development Authority review and approval.
Forward Looking Statements
Certain statements herein may be 'forward looking' statements that involve known and unknown risks, uncertainties and other factors that may cause the actual events to be materially different from any future events expressed or implied by such forward looking statements. Words such as 'may', 'will', 'expect', 'believe', 'plan', 'intend', 'should', 'anticipate' and other similar terminology are intended to identify forward looking statements. Forward looking statements in this press release include the intention of Lumine Group's acquisition of Datafusion Systems. Such forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future results, and will not necessarily be accurate indications of whether or not such results will be achieved, or when such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward looking statements reflect current assumptions and expectations regarding future events and are made as of the date hereof and Lumine Group assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances.
About Lumine Group
Lumine Group acquires, strengthens, and grows vertical market software businesses in the Communications and Media industry. Learn more at
www.luminegroup.com
.
About Datafusion Systems
Datafusion Systems has more than 30 years of experience in the field of communication and data analytics solutions. Our field-proven products are based on state-of-the-art developments at the forefront of communication analysis technologies. Our mission is to provide data intelligence to both law enforcement authorities and enterprise customers.
Media Relations Contact
Erini Andriopoulos
Senior Director, Marketing & Communications
Lumine Group
+1-437-353-4910
erini.andriopoulos@luminegroup.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Conavi Medical to Present at the Life Sciences Virtual Investor Forum June 12th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ('Conavi Medical' or the 'Company'), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO, will present live at the Life Sciences Virtual Investor Forum hosted by on June 12th, 2025 DATE: June 12th TIME: 2:00 PM ETLINK: REGISTER HERE This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights Upsized $20 million CAD financing led by U.S. institutional investors is expected to support finalizing product development of the next-generation Novasight Hybrid system, submit for regulatory clearance and enable commercial launch New U.S. intracoronary imaging guidelines from the American College of Cardiology and recent peer-reviewed research strongly validate Novasight's unique value proposition U.S. FDA 510(k) submission remains on track for calendar Q3 2025 About Conavi MedicalConavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the first system to combine both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. The Novasight Hybrid System has 510(k) clearance from the U.S. Food and Drug Administration; and regulatory approval for clinical use from Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labor and Welfare. For more information, visit About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Forward-Looking StatementsThis press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding Conavi and its business, which may include, but are not limited to, statements with respect to the anticipated use of proceeds from the April 2025 public offering, Conavi's exposure to the U.S. investment community, the commercialization and development of the Novasight Hybrid System and the achievement and timeline of key milestones towards commercialization and development of the Novasight Hybrid System. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking information or statements". Often but not always, forward-looking information or statements can be identified by the use of words such as "shall", "intends", "anticipate", "believe", "plan", "expect", "intend", "estimate" "anticipate" or any variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "might", "can", "could", "would" or "will" be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. They are based on assumptions and subject to risks and uncertainties. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, those listed in the "Risk Factors" section of the short form prospectus dated April 15, 2025 and the joint information circular of the Company dated August 30, 2024 (both of which are on the Company's profile at ). Although Conavi has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Conavi does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or regulatory authority has approved or disapproved the content of this press the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. Contacts: Conavi MedicalStefano PiconeChief Financial Officerir@ 483-0100 Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
CEO.CA's Inside the Boardroom: Mandalay Resources CEO: "This is Just the Beginning" After Beating Q1 & Announcing Merger
Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - (" the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality. Millions of people visit each year to connect with investors from around the world, share knowledge and view impactful stories about stocks, commodities, and emerging companies. Meet the Executive Shaping the Mining Landscape 'Inside the Boardroom' is more than just an interview series - it's a chance to gain firsthand knowledge from industry leaders, understanding their vision, challenges, and strategy. We invited Frazer Bourchier, President & CEO of Mandalay Resources Corp. (TSX: MND) (OTCQB: MNDJF) to talk to us about the company's rationale for a recently announced merger with Alkane Resources. We also discuss Mandalay's impressive revenue growth and large cash position, and what the company plans to do with capital allocation. Mandalay Resources(TSX: MND) (OTCQB: MNDJF) Cannot view this video? Visit: Tune in to 'Inside the Boardroom' each week and be part of the conversation that's shaping the business landscape. Visit or our YouTube page for hundreds more executive interviews from here. Interested in showcasing your company on 'Inside the Boardroom'? Get in touch with our team at sales@ for further details and opportunities. About The leading community for investors & traders in junior resource & venture stocks. is one of the most popular free financial websites and apps in Canada and for small-cap investors globally -- with industry leading audience engagement and mobile functionality. Since 2012, has brought millions of investors together from over 164 countries to discuss their portfolio holdings and find new investment opportunities. Download our App on iOS or Android marketplace or visit us today at to set up your free account. is a wholly owned subsidiary of EarthLabs, Inc. For further information please contact: Email: hello@ Neither the TSX Venture Exchange ("TSXV"), OTC Best Market "(OTCQX") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Cautionary Statement The information regarding any issuer contained or referred to in any interviews conducted by has been furnished by such issuer directly, and neither nor any of its affiliates or principals assumes any responsibility for the accuracy or completeness of such information or for any failure by an issuer to ensure disclosure of events or facts which may affect the significance or accuracy of any such information. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This news release contains forward-looking information which involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release may include, but is not limited to, the objectives, goals, future plans, statements regarding exploration results and exploration and/or development plans of companies featured on the platform. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, capital and operating costs varying significantly from estimates, the preliminary nature of metallurgical test results, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, fluctuations in commodity prices, delays in the development of projects, currency risk and the other risks involved in the applicable exploration and development industry, and those risks set out in the public documents of such companies filed on SEDAR or elsewhere from time to time. Undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
BIOREM Announces Approval of Normal Course Issuer Bid
GUELPH, ON, June 11, 2025 /CNW/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") is pleased to announce that the TSX Venture Exchange (the "TSXV") has approved its application to implement a normal course issuer bid("NCIB") for a portion of its common shares ("Common Shares"). Biorem believes that: (1) the repurchase of Common Shares would be an effective use of its cash resources and in the best interests of Biorem and its shareholders; (2) that the current market price of its Common shares does not fully reflect their underlying value; and (3) that current market conditions provide opportunities for the Company to acquire Common Shares at attractive prices. Pursuant to the NCIB notice filed with and accepted by the TSXV, the Company has been authorized to acquire up to a maximum of 806,872 Common Shares, or approximately 5% of the currently issued and outstanding Common Shares as of June 10, 2025, for cancelation. As of June 10, 2025, Biorem had 16,137,437 Common Shares issued and outstanding and a public float of 15,235,000 Common Shares. Purchases under the NCIB will commence on or about June 16, 2025 and will terminate on the earlier of: (i) one year from such commencement; or (ii) the date on which the Company has purchased the maximum number of Shares to be acquired under the NCIB. The NCIB will be conducted on behalf of the Company by Cormark Securities Inc. (the "Broker"). The purchase and payment for the Common Shares will be made in accordance with TSXV requirements at the market price of the Common Shares at the time of acquisition, plus brokerage fees, if any, charged by the Broker. Purchases under the NCIB will be made in accordance with applicable regulatory requirements through the facilities of the TSXV. All Common Shares purchased under the NCIB will be canceled upon their purchase. The Company intends to fund the purchases out of its available resources. To the Company's knowledge, none of the officers, or other insiders of the Company, or any associate of such person, or any associate of affiliate of the Company, has any present intention to sell any Shares to the Company pursuant to the NCIB. The Company has not purchased for cancellation any of its outstanding Shares within the 12 months preceding the filing of the NCIB notice with the TSXV. Advisory Regarding Forward-looking InformationThis news release contains "forward-looking information" within the meaning of applicable Canadian securities laws and "forward-looking statements" (and together with "forward-looking information", "FLI") . All statements other than statements of historical fact are FLI. The use of any of the words "anticipate", "believe", "could", "estimate", "expect", "future", "intend", "may", "plan", "potential", "predict", "should", "will" and similar expressions, (including negatives thereof) are intended to identify FLI. In particular, this news release includes (without limitation) forward-looking information and statements pertaining to the anticipated benefits of the NCIB. Readers are cautioned that the foregoing list of factors is not exhaustive. Although the FLI contained in this news release are based upon assumptions which management believes to be reasonable, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. With respect to FLI contained in this news release, Biorem has made assumptions regarding, among other things, the ability of the Company to achieve the benefits of the NCIB. The FLI included in this news release are made as of the date of this news release and are based on the information available to the Company at such time and, other than as required by law, Biorem disclaims any intention or obligation to update or revise any FLI, whether as a result of new information, future events, or otherwise. This news release and its contents should not be construed, under any circumstances, as investment, tax, or legal advice. About BIOREM Inc. BIOREM is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 2.000 installed systems worldwide, Biorem offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at SOURCE Biorem Inc. View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
